Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson's disease.
Yanling ShenLing DaiHaibo TianRunnan XuFuying LiZhuohang LiJeremy ZhouLiping WangJianghui DongLiyuan SunPublished in: Neuropsychiatric disease and treatment (2019)
The treatment with MgT is associated with an increase of Mg in the CSF. MgT, rather than MgSO4, can significantly attenuate MPTP-induced motor deficits and dopamine (DA) neuron loss.